The week's selected rheumatology studies, every Monday. https://currentrheuma.com/weekly/feed.xml 2026-11-08T17:16:45.214Z CurrentRheumahttps://currentrheuma.com/weekly/ https://currentrheuma.com/weekly/2026-w45/ 2026-11-08T17:16:45.214Z 2026-11-08T17:16:45.214Z

9 selected rheumatology studies from 8 journals. Featured: Effects of a Smartphone‐Enabled, Physician‐Supervised Treat‐to‐Target Model for Gout Management: A 12‐Month Randomized Controlled Trial; Denosumab biosimilar HLX14 versus EU-denosumab in postmenopausal women at high fracture risk: a randomized, double-blind, multicenter phase 3 trial; Factors associated with tocilizumab primary failure in the treatment of giant cell arteritis.

https://currentrheuma.com/weekly/2026-w44/ 2026-11-06T12:14:42.337Z 2026-11-06T12:14:42.337Z

56 selected rheumatology studies from 15 journals. Featured: Efficacy and safety of the TRPV1 agonist RTX-GRT7039 in patients with pain associated with knee osteoarthritis: Results from a phase 3, randomised, placebo-controlled trial; Better After CHoosing in rheumatoid arthritis (the BACH trial): patients who have the opportunity to choose their treatment are more satisfied; Rituximab vs Azathioprine for Eosinophilic Granulomatosis With Polyangiitis Maintenance Therapy: A Randomized Clinical Trial.